Search
Feed aggregator
Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive
Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive 4/17/2024
Cullinan Targets Autoimmune Market, Nabs $280M in Private Placement
Cullinan Targets Autoimmune Market, Nabs $280M in Private Placement 4/17/2024
GSK Touts Late-Stage Antibiotic Win in Gonorrhea, Long-Term Shingrix Vaccine Data
GSK Touts Late-Stage Antibiotic Win in Gonorrhea, Long-Term Shingrix Vaccine Data 4/17/2024
Arrowhead’s Plozasiran Poised for Dyslipidemia Market, $700M in Sales by 2032: GlobalData
Arrowhead’s Plozasiran Poised for Dyslipidemia Market, $700M in Sales by 2032: GlobalData 4/17/2024
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages
Amylyx and ALS, Continued ADC Excitement, Dire Drug Shortages 4/17/2024
C-Suite Shuffle: Bayer Continues Leadership Shakeup with Hires at Subsidiaries
C-Suite Shuffle: Bayer Continues Leadership Shakeup with Hires at Subsidiaries 4/17/2024
J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales
J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales 4/16/2024
Sandoz’s Biosimilar Skyrockets After CVS Removes AbbVie’s Humira from Formularies
Sandoz’s Biosimilar Skyrockets After CVS Removes AbbVie’s Humira from Formularies 4/16/2024
Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030
Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030 4/16/2024
Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review
Novartis Secures Phase III Fabhalta Win in IgAN as FDA Starts Priority Review 4/16/2024
Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug
Intra-Cellular Touts Phase III Major Depressive Disorder Results for Antipsychotic Drug 4/16/2024
Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome
Ultragenyx Eyes Pivotal Study After Mid-Stage Win in Angelman Syndrome 4/16/2024
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit 4/16/2024
FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf...
FDA Puts Clinical Hold on Neumora’s Schizophrenia Drug Due to Preclinical Saf... 4/15/2024
Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion
Roche Bispecific T Cell Engager Improves Survival in Lymphoma, Teeing up Label Expansion 4/15/2024
FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer
FDA Adcomm Backs New Surrogate Endpoint for Accelerated Approvals in Blood Cancer 4/15/2024
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment 4/15/2024
Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune
Genentech Walks Away From $3B Allogeneic T-Cell Pact with Adaptimmune 4/15/2024
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech 4/15/2024
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development 4/15/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target